SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-084992
Filing Date
2023-07-28
Accepted
2023-07-28 06:19:30
Documents
2
Period of Report
2023-07-27

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2321997-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2321997-2_4seq1.xml 4 5933
2 EXHIBIT 24 tm2321997-2_ex24.htm EX-24 6405
  Complete submission text file 0001104659-23-084992.txt   13846
Mailing Address 3 COLUMBUS CIRCLE, SUITE 1710 C/O ARALEZ PHARMACEUTICALS INC. NEW YORK NY 10019
Business Address
KOVEN ANDREW I (Reporting) CIK: 0001258673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37809 | Film No.: 231120115

Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Issuer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations